Recombinant multi-species CXCL12/SDF-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL12/SDF-1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This antimicrobial gene encodes a stromal cell-derived alpha chemokine member of the intercrine family. The encoded protein functions as the ligand for the G-protein coupled receptor, chemokine (C-X-C motif) receptor 4, and plays a role in many diverse cellular functions, including embryogenesis, immune surveillance, inflammation response, tissue homeostasis, and tumor growth and metastasis. Mutations in this gene are associated with resistance to human immunodeficiency virus type 1 infections. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
The Alternative Names of target: C-X-C motif chemokine 12,CXCL12,Cxcl12,IRH,Intercrine reduced in hepatomas (IRH,PBSF,Pbsf,Pre-B cell growth-stimulating factor (PBSF),SCYB12,SDF-1,SDF1,Scyb12,Sdf1,Stromal cell-derived factor 1,TLSF,TPAR1,Tlsf,Tpar1,hIRH),hSDF-1

Target products collectionGo to CXCL12/SDF-1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T04773-Ag-1/ GM-Tg-hg-T04773-Ag-2 Human CXCL12/SDF-1 protein Human
GM-Tg-rg-T04773-Ag-1/ GM-Tg-rg-T04773-Ag-2 Rat CXCL12/SDF-1 protein Rat
GM-Tg-mg-T04773-Ag-1/ GM-Tg-mg-T04773-Ag-2 Mouse CXCL12/SDF-1 protein Mouse
GM-Tg-cynog-T04773-Ag-1/ GM-Tg-cynog-T04773-Ag-2 Cynomolgus/Rhesus macaque CXCL12/SDF-1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T04773-Ag-1/ GM-Tg-felg-T04773-Ag-2 Feline CXCL12/SDF-1 protein Feline
GM-Tg-cang-T04773-Ag-1/ GM-Tg-cang-T04773-Ag-2 Canine CXCL12/SDF-1 protein Canine
GM-Tg-bovg-T04773-Ag-1/ GM-Tg-bovg-T04773-Ag-2 Bovine CXCL12/SDF-1 protein Bovine
GM-Tg-equg-T04773-Ag-1/ GM-Tg-equg-T04773-Ag-2 Equine CXCL12/SDF-1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T04773-Ag-1/ GM-Tg-hg-T04773-Ag-2; GM-Tg-rg-T04773-Ag-1/ GM-Tg-rg-T04773-Ag-2;
GM-Tg-mg-T04773-Ag-1/ GM-Tg-mg-T04773-Ag-2; GM-Tg-cynog-T04773-Ag-1/ GM-Tg-cynog-T04773-Ag-2;
GM-Tg-felg-T04773-Ag-1/ GM-Tg-felg-T04773-Ag-2; GM-Tg-cang-T04773-Ag-1/ GM-Tg-cang-T04773-Ag-2;
GM-Tg-bovg-T04773-Ag-1/ GM-Tg-bovg-T04773-Ag-2; GM-Tg-equg-T04773-Ag-1/ GM-Tg-equg-T04773-Ag-2
Products Name CXCL12/SDF-1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CXCL12/SDF-1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL12/SDF-1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.